{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:22:49Z","timestamp":1791685369355,"version":"4.3.4"},"reference-count":52,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T00:00:00Z","timestamp":1424908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical symptoms of Alzheimer disease (<jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>) include a gradual memory loss and subsequent dementia, and neuropathological deposition of senile plaques and neurofibrillary tangles. At the molecular level, <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> subjects present overt amyloid \u03b2 (A\u03b2) production and tau hyperphosphorylation. A\u03b2 species have been proposed to overactivate the phosphoinositide3\u2010kinase (<jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>3K)\/Akt\/mammalian target of rapamycin (<jats:styled-content style=\"fixed-case\">mTOR<\/jats:styled-content>) axis, which plays a central role in proteostasis. The current study investigated the status of the <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>3K\/Akt\/<jats:styled-content style=\"fixed-case\">mTOR<\/jats:styled-content> pathway in post\u2010mortem tissue from the inferior parietal lobule (<jats:styled-content style=\"fixed-case\">IPL<\/jats:styled-content>) at three different stages of <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>: late <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>, amnestic mild cognitive impairment (<jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>) and pre\u2010clinical <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">PCAD<\/jats:styled-content>). Our findings suggest that the alteration of <jats:styled-content style=\"fixed-case\">mTOR<\/jats:styled-content> signaling and autophagy occurs at early stages of <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>. We found a significant increase in A\u03b2 (1\u201342) levels, associated with reduction in autophagy (Beclin\u20101 and <jats:styled-content style=\"fixed-case\">LC<\/jats:styled-content>\u20103) observed in <jats:styled-content style=\"fixed-case\">PCAD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> MCI<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> subjects. Related to the autophagy impairment, we found a hyperactivation of <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>3K\/Akt\/<jats:styled-content style=\"fixed-case\">mTOR<\/jats:styled-content> pathway in <jats:styled-content style=\"fixed-case\">IPL<\/jats:styled-content> of <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> subjects, but not in <jats:styled-content style=\"fixed-case\">PCAD<\/jats:styled-content>, along with a significant decrease in phosphatase and tensin homolog. An increase in two <jats:styled-content style=\"fixed-case\">mTOR<\/jats:styled-content> downstream targets, p70S6K and 4<jats:styled-content style=\"fixed-case\">EBP<\/jats:styled-content>1, occurred in <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content> subjects. Both <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content> subjects showed increased, insulin receptor substrate 1, a candidate biomarker of brain insulin resistance, and <jats:styled-content style=\"fixed-case\">GSK<\/jats:styled-content>\u20103\u03b2, a kinase targeting tau phosphorylation. Nevertheless, tau phosphorylation was increased in the clinical groups. The results hint at a link between A\u03b2 and the <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>3K\/Akt\/<jats:styled-content style=\"fixed-case\">mTOR<\/jats:styled-content> axis and provide further insights into the relationship between <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> pathology and insulin resistance. In addition, we speculate that the alteration of <jats:styled-content style=\"fixed-case\">mTOR<\/jats:styled-content> signaling in the <jats:styled-content style=\"fixed-case\">IPL<\/jats:styled-content> of <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content> subjects, but not in <jats:styled-content style=\"fixed-case\">PCAD<\/jats:styled-content>, is due to the lack of substantial increase in oxidative stress.\n<jats:boxed-text content-type=\"graphic\" position=\"anchor\"><jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/jnc13037-fig-0007-m.png\"><jats:alt-text>image<\/jats:alt-text><\/jats:graphic><\/jats:boxed-text>\n<\/jats:p><jats:p>The figure represents the three different stages of Alzheimer Disease: Preclinical Alzheimer Disease (PCAD), Mild cognitive impairment (MCI) and late stage of Alzheimer Disease. The progression of the disease is associated with a reduction in autophagy (Beclin\u20101 and LC\u20103) observed in Inferior parietal lobe of PCAD, MCI, and AD subjects (light red). Related to the autophagy impairment, the graph shows the impairment of PI3K\/Akt\/mTOR in MCI and AD subjects (dark red).<\/jats:p>","DOI":"10.1111\/jnc.13037","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T12:56:34Z","timestamp":1422363394000},"page":"739-749","source":"Crossref","is-referenced-by-count":325,"title":["Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre\u2010clinical AD, amnestic mild cognitive impairment and late\u2010stage AD"],"prefix":"10.1111","volume":"133","author":[{"given":"Antonella","family":"Tramutola","sequence":"first","affiliation":[{"name":"Department of Biochemical Sciences Sapienza University of Rome Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Triplett","sequence":"additional","affiliation":[{"name":"Department of Chemistry University of Kentucky Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Di Domenico","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences Sapienza University of Rome Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Niedowicz","sequence":"additional","affiliation":[{"name":"Sanders\u2010Brown Center on Aging University of Kentucky Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Sanders\u2010Brown Center on Aging University of Kentucky Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Coccia","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences Sapienza University of Rome Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Perluigi","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences Sapienza University of Rome Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Allan","family":"Butterfield","sequence":"additional","affiliation":[{"name":"Department of Chemistry University of Kentucky Lexington Kentucky USA"},{"name":"Sanders\u2010Brown Center on Aging University of Kentucky Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.04.011"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-101083"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63687-5"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600251"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-14"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02422.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90437.2008"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.02.016"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2007-12107"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(01)02173-6"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2006-10407"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20140772"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.06.010"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.100420"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.10.001"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.08.006"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501707200"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.08.021"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.112"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809158106"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720512799015037"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06290.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.04.013"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.11.014"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02949.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e12-05-0337"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00833-4"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002369"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.31.19547"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181772794"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(01)00234-0"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06168"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04833.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.5.5.8626"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00577-5"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2009.00283.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025416"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.21.7428-7438.2002"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2008.04.002"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3232"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2009-1179"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST20120080"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.04.007"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01388.x"},{"key":"e_1_2_7_46_1","first-page":"2190","article-title":"The autophagy\u2010related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford F.","year":"2008","journal-title":"J. Clin. Invest."},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0909142"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59903"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M610390200"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2003.12.005"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-3"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2008.10.014"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7703com"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjnc.13037","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjnc.13037","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jnc.13037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T22:57:52Z","timestamp":1696287472000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jnc.13037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/jnc.13037"],"URL":"https:\/\/doi.org\/10.1111\/jnc.13037","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}